Citations

Clear

6273 citation(s) found for "To, Andrew".

Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
Ochoa-Rios, Shaaron , Blaschke, Calvin R.K. , Wang, Mengjun , Peterson, Kendell D. , DelaCourt, Andrew , Grauzam, Stéphane Elie , Lewin, David , Angel, Peggi M. , Roberts, Lewis R. , Drake, Richard R. , Mehta, Anand S. , Angel, Peggi , Drake, Richard , Roberts, Lewis R

Mayo Clinic

Cancer Research Communications | February 13, 2023 | Volume: 3 | Issue: 3 | Pages: 383-394

10.1158/2767-9764.crc-22-0422 | PMID 36890858 Get It

There is an urgent need for the identification of reliable prognostic biomarkers for patients with intrahepatic cholangiocarcinoma (iCCA) and alterations in N-glycosylation have demonstrated an immense potential to be used as diagnostic strategies for many cancers, including hepatocellular carcinoma (HCC). N-glycosylation is one of the most common post-translational modifications known to be altered based on the status of the cell. N-glycan structures on glycoproteins can be modified based on the addition or removal of specific N-glycan residues, some of which have been linked to liver diseases. However, little is known concerning the N-glycan alterations that are associated with iCCA. We characterized the N-glycan modifications quantitatively and qualitatively in three cohorts, consisting of two tissue cohorts: a discovery cohort (n = 104 cases) and a validation cohort (n = 75), and one independent serum cohort consisting of patients with iCCA, HCC, or benign chronic liver disease (n = 67). N-glycan analysis in situ was correlated to tumor regions annotated on histopathology and revealed that bisected fucosylated N-glycan structures were specific to iCCA tumor regions. These same N-glycan modifications were significantly upregulated in iCCA tissue and serum relative to HCC and bile duct disease, including primary sclerosing cholangitis (PSC) (P < 0.0001). N-glycan modifications identified in iCCA tissue and serum were used to generate an algorithm that could be used as a biomarker of iCCA. We demonstrate that this biomarker algorithm quadrupled the sensitivity (at 90% specificity) of iCCA detection as compared with carbohydrate antigen 19-9, the current “gold standard” biomarker of CCA. Significance: This work elucidates the N-glycan alterations that occur directly in iCCA tissue and utilizes this information to discover serum biomarkers that can be used for the noninvasive detection of iCCA.
Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes—A Comprehensive Review
Ohno, Kinji , Ohkawara, Bisei , Shen, Xin‐Ming , Selcen, Duygu , Engel, Andrew G. , Shen, Xin-Ming

Mayo Clinic

International Journal of Molecular Sciences | February 13, 2023 | Volume: 24 | Issue: 4 | Pages: 3730

10.3390/ijms24043730 | PMID 36835142 Get It

Congenital myasthenic syndromes (CMS) are a heterogeneous group of disorders characterized by impaired neuromuscular signal transmission due to germline pathogenic variants in genes expressed at the neuromuscular junction (NMJ). A total of 35 genes have been reported in CMS (AGRN, ALG14, ALG2, CHAT, CHD8, CHRNA1, CHRNB1, CHRND, CHRNE, CHRNG, COL13A1, COLQ, DOK7, DPAGT1, GFPT1, GMPPB, LAMA5, LAMB2, LRP4, MUSK, MYO9A, PLEC, PREPL, PURA, RAPSN, RPH3A, SCN4A, SLC18A3, SLC25A1, SLC5A7, SNAP25, SYT2, TOR1AIP1, UNC13A, VAMP1). The 35 genes can be classified into 14 groups according to the pathomechanical, clinical, and therapeutic features of CMS patients. Measurement of compound muscle action potentials elicited by repetitive nerve stimulation is required to diagnose CMS. Clinical and electrophysiological features are not sufficient to identify a defective molecule, and genetic studies are always required for accurate diagnosis. From a pharmacological point of view, cholinesterase inhibitors are effective in most groups of CMS, but are contraindicated in some groups of CMS. Similarly, ephedrine, salbutamol (albuterol), amifampridine are effective in most but not all groups of CMS. This review extensively covers pathomechanical and clinical features of CMS by citing 442 relevant articles.
A practical guide to the development and deployment of deep learning models for the orthopedic surgeon: part II
Kelly, Bryan T. , Nawabi, Danyal H. , Pearle, Andrew D. , Martin, R. Kyle , Pareek, Ayoosh , Sanchez-Sotelo, Joaquin, Pareek, Ayoosh , Oeding, Jacob F. , Williams, Riley J. , Camp, Christopher L. , Sánchez‐Sotelo, Joaquín , Karlsson, Jón , Jang, Seong J.

Mayo Clinic

Knee Surgery, Sports Traumatology, Arthroscopy | February 11, 2023 | Volume: 31 | Issue: 5 | Pages: 1635-1643

10.1007/s00167-023-07338-7 | PMID 36773057 Get It

AbstractDeep learning has the potential to be one of the most transformative technologies to impact orthopedic surgery. Substantial innovation in this area has occurred over the past 5 years, but clinically meaningful advancements remain limited by a disconnect between clinical and technical experts. That is, it is likely that few orthopedic surgeons possess both the clinical knowledge necessary to identify orthopedic problems, and the technical knowledge needed to implement deep learning‐based solutions. To maximize the utilization of rapidly advancing technologies derived from deep learning models, orthopedic surgeons should understand the steps needed to design, organize, implement, and evaluate a deep learning project and its workflow. Equipping surgeons with this knowledge is the objective of this three‐part editorial review. Part I described the processes involved in defining the problem, team building, data acquisition, curation, labeling, and establishing the ground truth. Building on that, this review (Part II) provides guidance on pre‐processing and augmenting the data, making use of open‐source libraries/toolkits, and selecting the required hardware to implement the pipeline. Special considerations regarding model training and evaluation unique to deep learning models relative to “shallow” machine learning models are also reviewed. Finally, guidance pertaining to the clinical deployment of deep learning models in the real world is provided. As in Part I, the focus is on applications of deep learning for computer vision and imaging.
Bayesian penalized likelihood PET reconstruction impact on quantitative metrics in diffuse large B-cell lymphoma
Young, Jason R. , Mugu, Vamshi , Johnson, Geoffrey B. , Ehman, Eric C. , Packard, Annie T. , Homb, Andrew, Nathan, Mark A., Thanarajasingam, Gita , Kemp, Bradley J. , Mugu, Vamshi K, Homb, Andrew C, Johnson, Geoffrey B , Young, Jason R

Mayo Clinic

Medicine | February 10, 2023 | Volume: 102 | Issue: 6 | Pages: e32665

10.1097/md.0000000000032665 | PMID 36820562 Get It

Evaluate the quantitative, subjective (Deauville score [DS]) and reader agreement differences between standard ordered subset expectation maximization (OSEM) and Bayesian penalized likelihood (BPL) positron emission tomography (PET) reconstruction methods. A retrospective review of 104 F-18 fluorodeoxyglucose PET/computed tomography (CT) exams among 52 patients with diffuse large B-cell lymphoma. An unblinded radiologist moderator reviewed both BPL and OSEM PET/CT exams. Four blinded radiologists then reviewed the annotated cases to provide a visual DS for each annotated lesion. Significant (P < .001) differences in BPL and OSEM PET methods were identified with greater standard uptake value (SUV) maximum and SUV mean for BPL. The DS was altered in 25% of cases when BPL and OSEM were reviewed by the same radiologist. Interobserver DS agreement was higher for OSEM (>1 cm lesion = 0.89 and ≤1 cm lesion = 0.84) compared to BPL (>1 cm lesion = 0.85 and ≤1 cm lesion = 0.81). Among the 4 readers, average intraobserver visual DS agreement between OSEM and BPL was 0.67 for lesions >1cm and 0.4 for lesions ≤1 cm. F-18 Fluorodeoxyglucose PET/CT of diffuse large B-cell lymphoma reconstructed with BPL has higher SUV values, altered DSs and reader agreement when compared to OSEM. This report finds volumetric PET measurements such as metabolic tumor volume to be similar between BPL and OSEM PET reconstructions. Efforts such as adoption of European Association Research Ltd accreditation should be made to harmonize PET data with an aim at balancing the need for harmonization and sensitivity for lesion detection.
Evaluation of Scapholunate Injury and Repair with Dynamic (4D) CT: A Preliminary Report of Two Cases
Zhao, Kristin D. , Lopez, Cesar , Fautsch, Kalli J., Holmes, David R. , Moran, Steven L. , Thoreson, Andrew R. , Trentadue, Taylor P. , Trentadue, Taylor P , Fautsch, Kalli, Holmes Iii, David R, Trentadue, Taylor P , Breighner, Ryan , Leng, Shuai , III, David R. Holmes, Kakar, Sanjeev

Mayo Clinic

Journal of Wrist Surgery | February 9, 2023 | Volume: 12 | Issue: 03 | Pages: 248-260

10.1055/s-0042-1758159 | PMID 37223378 Get It

Abstract Background In predynamic or dynamic scapholunate (SL) instability, standard diagnostic imaging may not identify SL interosseous ligament (SLIL) injury, leading to delayed detection and intervention. This study describes the use of four-dimensional computed tomography (4DCT) in identifying early SLIL injury and following injured wrists to 1-year postoperatively. Description of Technique 4DCT acquires a series of three-dimensional volume data with high temporal resolution (66 ms). 4DCT-derived arthrokinematic data can be used as biomarkers of ligament integrity. Patients and Methods This study presents the use of 4DCT in a two-participant case series to assess changes in arthrokinematics following unilateral SLIL injury preoperatively and 1-year postoperatively. Patients were treated with volar ligament repair with volar capsulodesis and arthroscopic dorsal capsulodesis. Arthrokinematics were compared between uninjured, preoperative injured, and postoperative injured (repaired) wrists. Results 4DCT detected changes in interosseous distances during flexion-extension and radioulnar deviation. Generally, radioscaphoid joint distances were greatest in the uninjured wrist during flexion-extension and radioulnar deviation, and SL interval distances were smallest in the uninjured wrist during flexion-extension and radioulnar deviation. Conclusion 4DCT provides insight into carpal arthrokinematics during motion. Distances between the radioscaphoid joint and SL interval can be displayed as proximity maps or as simplified descriptive statistics to facilitate comparisons between wrists and time points. These data offer insight into areas of concern for decreased interosseous distance and increased intercarpal diastasis. This method may allow surgeons to assess whether (1) injury can be visualized during motion, (2) surgery repaired the injury, and (3) surgery restored normal carpal motion. Level of Evidence Level IV, Case series.
Griseofulvin Radiosensitizes Non–Small Cell Lung Cancer Cells and Activates cGAS
Wang, Xing , Raman, Natasha , Lemtiri-Chlieh, Ghali , Chang, Jinhee , Jagtap, Shreya , Chowdhury, Dipanwita D. , Ballew, Matthew , Carrieri, Francesca A. , Nguyen, Triet , Nugent, Katriana , Peck, Travis , Levine, Michelle S. , Chan, Aaron , Lam, Christine , Malek, Reem , Hoang, Tung , Phillips, Ryan , Cheng, Zhuoan , Taparra, Kekoa , Connis, Nick , Hann, Christine L. , Holland, Andrew J. , Lafargue, Audrey , Chowdhury, Dipanwita Dutta , Carrieri, Francesca Anna , Holland, Andrew , Tran, Phuoc T , Lafargue, Audrey , Wang, Hailun , Peck, Travis

Mayo Clinic

Molecular Cancer Therapeutics | February 8, 2023 | Volume: 22 | Issue: 4 | Pages: 519-528

10.1158/1535-7163.mct-22-0191 | PMID 36752776 Get It

Abstract Extra copies of centrosomes are frequently observed in cancer cells. To survive and proliferate, cancer cells have developed strategies to cluster extra-centrosomes to form bipolar mitotic spindles. The aim of this study was to investigate whether centrosome clustering (CC) inhibition (CCi) would preferentially radiosensitize non–small cell lung cancer (NSCLC). Griseofulvin (GF; FDA-approved treatment) inhibits CC, and combined with radiation treatment (RT), resulted in a significant increase in the number of NSCLC cells with multipolar spindles, and decreased cell viability and colony formation ability in vitro. In vivo, GF treatment was well tolerated by mice, and the combined therapy of GF and radiation treatment resulted in a significant tumor growth delay. Both GF and radiation treatment also induced the generation of micronuclei (MN) in vitro and in vivo and activated cyclic GMP-AMP synthase (cGAS) in NSCLC cells. A significant increase in downstream cGAS-STING pathway activation was seen after combination treatment in A549 radioresistant cells that was dependent on cGAS. In conclusion, GF increased radiation treatment efficacy in lung cancer preclinical models in vitro and in vivo. This effect may be associated with the generation of MN and the activation of cGAS. These data suggest that the combination therapy of CCi, radiation treatment, and immunotherapy could be a promising strategy to treat NSCLC.
Measurement of enhanced vasa vasorum density in a porcine carotid model using photon counting detector CT
Marsh, Jeffrey F., Vercnocke, Andrew J. , Tao, Shengzhen , Anderson, Jill , Ritman, Erik L., Rajendran, Kishore , Anderson, Jill L, Leng, Shuai , McCollough, Cynthia H , Rajendran, Kishore , Leng, Shuai , McCollough, Cynthia H.

Mayo Clinic

Journal of Medical Imaging | February 6, 2023 | Volume: 10 | Issue: 01 | Pages: No page available

10.1117/1.jmi.10.1.016001 | PMID 36778671 Get It

Physiological Demands of a Self-Paced Firefighter Air-Management Course and Determination of Work Efficiency
Jagim, Andrew R. , Luedke, Joel, Dobbs, Ward C. , Markert, Adam, Zapp, Annette , Askow, Andrew T. , Kesler, Richard M. , Fields, Jennifer B. , Jones, Margaret T. , Erickson, Jacob L. , Luedke, Joel A, Askow, Andrew T , Jones, Margaret T , Jagim, Andrew R , Almonroeder, Thomas Gus

Mayo Clinic

Journal of Functional Morphology and Kinesiology | February 6, 2023 | Volume: 8 | Issue: 1 | Pages: 21

10.3390/jfmk8010021 | PMID 36810505 Get It

Firefighters often complete air management courses (AMC) to assess the ability to tolerate personal protective equipment, appropriately manage the breathing system and assess occupational performance. Little information is known relative to the physiological demands of AMCs, nor how to assess work efficiency in order to characterize occupational performance and evaluate progress. Purpose: To assess the physiological demands of an AMC and examine differences across BMI categories. A secondary aim was to develop an equation to assess work efficiency in firefighters. Methods: Fifty-seven firefighters (Women, n = 4; age: 37.2 ± 8.4 yr.; height: 182.0 ± 6.9 cm; body mass: 90.8 ± 13.1 kg; BMI: 27.8 ± 3.6 kg·m−2) completed an AMC per routine evaluation while wearing a department issued self-contained breathing apparatus and full protective gear. Course completion time, starting pounds per square inch (PSI) on the air cylinder, changes in PSI, and distance traveled were recorded. All firefighters were equipped with a wearable sensor integrated with a triaxial accelerometer and telemetry to assess movement kinematics, heart rate, energy expenditure, and training impulse. The AMC consisted of an initial section involving a hose line advance, rescue (body drag), stair climb, ladder raise, and forcible entry. This section was followed by a repeating loop, which consisted of a stair climb, search, hoist, and recovery walk. Firefighters repeated the course loop until the self-contained breathing apparatus air supply pressure reached 200 PSI, at which time they were instructed to lay down until the PSI reached zero. Results: Average completion time was 22.8 ± 1.4 min, with a mean distance of 1.4 ± 0.3 km and an average velocity of 2.4 ± 1.2 m·s−1. Throughout the AMC, the mean heart rate was 158.7 ± 11.5 bpm equating to 86.8 ± 6.3% of the age-predicted max heart rate and a training impulse of 55 ± 3 AU. Mean energy expenditure was 464 ± 86 kcals and work efficiency was 49.8 ± 14.9 km·PSI−1·s. Regression analysis determined that fat-free mass index (R2 = 0.315; β = −5.069), body fat percentage (R2 = 0.139; β = −0.853), fat-free mass (R2 = 0.176; β = −0.744), weight (R2 = 0.329; β = −0.681), and age (R2 = 0.096; β = −0.571) were significant predictors of work efficiency. Conclusions: The AMC is a highly aerobic task with near-maximal heart rates reached throughout the course. Smaller and leaner individuals achieved a higher degree of work efficiency during the AMC.
Interventricular-Septal Output While Supported on Left Ventricular Assist Device Therapy
Inglis, Sara S. , Villavicencio, Mauricio T., Spencer, Philip J. , Schettle, Sarah , Stulak, John M., Clavell, Alfredo L. , Kushwaha, Sudhir S. , Rosenbaum, Andrew , Schettle, Sarah D., Rosenbaum, Andrew N , Inglis, Sara S , Villavicencio, Mauricio A. , Behfar, Atta

Mayo Clinic

ASAIO Journal | February 2, 2023 | Volume: 69 | Issue: 5 | Pages: 424-428

10.1097/mat.0000000000001851 | PMID 36730725 Get It

The effects of left ventricular unloading on septal function in patients with left ventricular assist devices (LVADs) have not been well characterized in vivo. The purpose of this study was to evaluate the relationship between markers of septal function with echocardiography in relationship to RV dysfunction and late RV failure after LVAD implantation. A retrospective study was conducted of patients supported on centrifugal-flow LVADs implanted over a 10-year period. Echocardiographic data were collected pre-operatively and up to 2 years after implantation. Interventricular septum (IVS) measurements were taken at end-systole and end-diastole. Interventricular-septal output (ISO) was calculated using the formula: (IVSs–IVSd)×heart rate. A total of 110 patients were included. An immediate and sustained reduction in both lateral annulus systolic velocity (RVS’) and TAPSE were observed after implant (p < 0.0001). However, ISO gradually decreased over time (p < 0.0001). While ISO was not predictive of late RV failure, a decrease in ISO by 25% or greater from pre-implant to hospital discharge was associated with late RV failure (OR 4.8; 95% CI, 1.4–16.5; p = 0.012) even after adjusting for relevant clinical variables (p ≤ 0.01 for each model). RV function is known to be influenced by mechanical ventricular interdependence and we demonstrate that measurement of ISO may be a useful marker in assessing RV dysfunction and predicting RV failure in patients following LVAD implantation.
Locked Plating versus Nailing for Proximal Tibia Fractures: A Multicenter RCT
Dunbar, Robert P. , Jones, Clifford B. , Ostrum, Robert F. , Humphrey, Catherine A. , Ricci, William M. , Phieffer, Laura S. , Teague, David , Sagi, H. Claude , Pollak, Andrew N. , Sems, Andrew, Pape, Hans‐Christoph , Perez, Edward A., Egol, Kenneth A. , Schmidt, Andrew H. , Morshed, Saam , Tornetta, Paul

Mayo Clinic

Journal of Orthopaedic Trauma | February 2, 2023 | Volume: 37 | Issue: 4 | Pages: 155-160

10.1097/bot.0000000000002537 | PMID 36729919 Get It

Objectives: The main 2 forms of treatment for extraarticular proximal tibial fractures are intramedullary nailing (IMN) and locked lateral plating (LLP). The goal of this multicenter, randomized controlled trial was to determine whether there are significant differences in outcomes between these forms of treatment. Design: Multicenter, randomized controlled trial. Setting: 16 academic trauma centers. Patients/Participants: 108 patients were enrolled. 99 patients were followed for 12 months. 52 patients were randomized to IMN, and 47 patients were randomized to LLP. Intervention: IMN or lateral locked plating. Main Outcome Measurements: Functional scoring including Short Musculoskeletal Functional Assessment, Bother Index, EQ-5Dindex and EQ-5DVAS. Secondary measures included alignment, operative time, range of motion, union rate, pain, walking ability, ability to manage stairs, need for ambulatory aid and number, and complications. Results: Functional testing demonstrated no difference between the groups, but both groups were still significantly affected 12 months postinjury. Similarly, there was no difference in time of surgery, alignment, nonunion, pain, walking ability, ability to manage stairs, need for ambulatory support, or complications. Conclusions: Both IMN and LLP provide for similar outcomes after these fractures. Patients continue to improve over the course of the year after injury but remain impaired even 1 year later. Level of Evidence: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.